Showing results (91-100 of 113) with videos related to

Sort By:
Pageof 12
Current Eye Research|April 13, 2023
A Comparison of the Corneal Thickness Following Descemet's Stripping Automated Endothelial Keratoplasty and Descemet's Membrane Endothelial KeratoplastyChihiro Sunouchi, Takahiko Hayashi, Toshiki Shimizu, et al.
Ophthalmology|December 27, 2016
Steroid-Sparing Effect of 0.1% Tacrolimus Eye Drop for Treatment of Shield Ulcer and Corneal Epitheliopathy in Refractory Allergic Ocular DiseasesDai Miyazaki, Atsuki Fukushima, Yuichi Ohashi, et al.
Frontiers in Immunology|March 12, 2026
Non-HLA antibody trajectories may predict kidney transplant outcomesRaja Rajalingam, Tara K Sigdel, Stalinraja Maruthamuthu, et al.
Allergology International : Official Journal of the Japanese Society of Allergology|February 25, 2012
Blood level of tacrolimus in patients with severe allergic conjunctivitis treated by 0.1% tacrolimus ophthalmic suspensionNobuyuki Ebihara, Yuichi Ohashi, Hiroshi Fujishima, et al.
Nippon Ganka Gakkai Zasshi|July 9, 2011
[A prospective, observational, all-prescribed-patients study of cyclosporine 0.1% ophthalmic solution in the treatment of vernal keratoconjunctivitis]Etsuko Takamura, Eiichi Uchio, Nobuyuki Ebihara, et al.
The British Journal of Ophthalmology|April 4, 2014
Therapeutic effects of 0.1% tacrolimus eye drops for refractory allergic ocular diseases with proliferative lesion or corneal involvementAtsuki Fukushima, Yuichi Ohashi, Nobuyuki Ebihara, et al.
Japanese Journal of Ophthalmology|October 7, 2020
Reduced steroid-induced intraocular pressure elevation in tacrolimus-treated refractory allergic ocular diseasesDai Miyazaki, Daisuke Shimizu, Atsuki Fukushima, et al.
Allergology International : Official Journal of the Japanese Society of Allergology|November 19, 2020
Japanese guidelines for allergic conjunctival diseases 2020Dai Miyazaki, Etsuko Takamura, Eiichi Uchio, et al.
Transplantation|July 23, 2024
Efficacy and Safety of Bleselumab in Preventing the Recurrence of Primary Focal Segmental Glomerulosclerosis in Kidney Transplant Recipients: A Phase 2a, Randomized, Multicenter StudyJun Shoji, William C Goggins, Jason R Wellen, et al.
Transplantation Direct|June 5, 2026
CTLA4-Ig + Anti-IL-6/IL-6R Treatment Results in Long-term Allograft Survival and Function in Highly HLA-sensitized PatientsStanley C Jordan, Sindhu Chandran, Noriko Ammerman, et al.
Pageof 12